A Two-year Follow-up of Zidovudine Plus Lamivudine Combined with Indinavir in Antivival Naive HIV-infected Patients
-
- AIZAWA Saori
- AIDS Clinical Center, International Medical Center of Japan
-
- HACHIYA-SAKAI Atsuko
- AIDS Clinical Center, International Medical Center of Japan
-
- IDA Setsuko
- AIDS Clinical Center, International Medical Center of Japan
-
- TACHIKAWA Natsuo
- AIDS Clinical Center, International Medical Center of Japan
-
- KIKUCHI Yoshimi
- AIDS Clinical Center, International Medical Center of Japan
-
- AOKI Makoto
- AIDS Clinical Center, International Medical Center of Japan
-
- YASUOKA Akira
- AIDS Clinical Center, International Medical Center of Japan
-
- OKA Shinichi
- AIDS Clinical Center, International Medical Center of Japan
Bibliographic Information
- Other Title
-
- 抗HIV無治療患者に対するZidovudine/Lamivudine/Indinavir併用療法の2年間の治療経過
- コウHIV ムチリョウ カンジャ ニ タイスル Zidovudine Lamivudine Indinavir ヘイヨウ リョウホウ ノ 2ネンカン ノ チリョウ ケイカ
Search this article
Abstract
Efficacy of a 3-drug combination (Zidovudine (AZT) +Lamivudine (3TC) +Indinavir (IDV)) has been evaluated in 17 anti-viral naive patients with HIV infection for 24 months. Our genotypic resistance assay was able to analyze more than 80% of the patients whose viral load (VL) was over 3, 000 copies/ml. This therapy was continued in 11 patients (65%) for 24 months. Among them, VL was undetectable (VI<400copies/ml) in patients at 24 month (47% by intent-to-treat, 72% by on treatment). Of the 11 patients, a 3TC resistance-related mutantion was detected in only one case. The therapy was discontinued in 6 cases. Main reasons of the discontinuation were side effects. However, if the therapy was switched to other combinations when VL was undetectable, VL remained undetectable in 5 cases at 24 month.
Journal
-
- Kansenshogaku Zasshi
-
Kansenshogaku Zasshi 74 (2), 128-133, 2000
The Japanese Association for Infectious Diseases
- Tweet
Details 詳細情報について
-
- CRID
- 1390282680025138048
-
- NII Article ID
- 130004330848
- 10008713279
-
- NII Book ID
- AN00047715
-
- ISSN
- 1884569X
- 03875911
-
- NDL BIB ID
- 5291756
-
- PubMed
- 10741003
-
- Data Source
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- Abstract License Flag
- Disallowed